Mendel Money Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.21M Buy
11,908
+161
+1% +$29.9K 0.98% 36
2025
Q1
$2.46M Sell
11,747
-528
-4% -$111K 1.17% 28
2024
Q4
$2.18M Buy
12,275
+760
+7% +$135K 0.97% 35
2024
Q3
$2.27M Sell
11,515
-1,552
-12% -$306K 0.98% 32
2024
Q2
$2.24M Sell
13,067
-216
-2% -$37K 1.05% 33
2024
Q1
$2.42M Sell
13,283
-396
-3% -$72.1K 1.12% 33
2023
Q4
$2.12M Buy
13,679
+4,467
+48% +$692K 1.02% 33
2023
Q3
$1.37M Buy
9,212
+470
+5% +$70.1K 0.74% 40
2023
Q2
$1.18M Buy
8,742
+854
+11% +$115K 0.61% 44
2023
Q1
$1.26M Sell
7,888
-7,141
-48% -$1.14M 0.68% 40
2022
Q4
$2.43M Buy
15,029
+350
+2% +$56.6K 1.38% 28
2022
Q3
$1.97M Buy
14,679
+685
+5% +$91.9K 1.23% 29
2022
Q2
$2.14M Sell
13,994
-655
-4% -$100K 1.28% 28
2022
Q1
$2.38M Buy
14,649
+4,364
+42% +$708K 1.16% 32
2021
Q4
$1.39M Sell
10,285
-410
-4% -$55.5K 0.8% 30
2021
Q3
$1.15M Sell
10,695
-45
-0.4% -$4.86K 0.72% 32
2021
Q2
$1.21M Sell
10,740
-550
-5% -$62K 0.76% 34
2021
Q1
$1.22M Sell
11,290
-100
-0.9% -$10.8K 0.8% 32
2020
Q4
$1.22M Buy
11,390
+320
+3% +$34.3K 0.85% 29
2020
Q3
$970K Buy
11,070
+120
+1% +$10.5K 0.76% 31
2020
Q2
$1.08M Buy
+10,950
New +$1.08M 0.95% 28
2019
Q4
$922K Sell
10,412
-180
-2% -$15.9K 0.8% 29
2019
Q3
$802K Buy
10,592
+200
+2% +$15.1K 0.74% 30
2019
Q2
$756K Buy
+10,392
New +$756K 0.72% 30
2018
Q3
$947K Buy
+10,017
New +$947K 0.92% 29
2017
Q4
$1.04M Buy
+10,751
New +$1.04M 1% 29
2015
Q2
$746K Hold
11,103
0.69% 35
2015
Q1
$650K Hold
11,103
0.6% 34
2014
Q4
$727K Sell
11,103
-300
-3% -$19.6K 0.68% 35
2014
Q3
$659K Buy
+11,403
New +$659K 0.64% 36